RI
RxWare, Inc.
SEC filingOther Health Care · Wilmington, DE
Amount raised$6.1Msold at filing
Total offering$6.7M$600K still open
Investors in the raise12count reported to the SEC
FiledAug 14, 2025first sale Aug 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David MatiasDirector
Raeanna LewarneExecutive Officer, Director
Shlomi AflaloExecutive Officer, Director
Harry TotonisDirector
Farhan AshrafDirector
Adam FineDirector
Executive officers, directors and promoters as listed on the Form D.